Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin

PaperCitations, authors & open-access status

HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 227 citations, 2014 year and closed oa status.

227
Citations
2014
Year
closed
OA Status

Related on ScholarIQ

Fred Yang
Author
Murray Stewart
Author
Diabetes Care
Journal
Diabetes Treatment and Management
Topic
Diabetes Treatment and Management
Topic
Diabetes Management and Research
Topic
470M+ articles · free account